Halozyme Therapeutics, Inc. - Common Stock (NQ:HALO)Price and VolumeDetailed Quote
Top NewsMore NewsPerformanceMore NewsRead More
1 Surging Stock Worth Investigating and 2 We Brush Off
January 11, 2026
Halozyme Therapeutics (HALO): Buy, Sell, or Hold Post Q3 Earnings?
January 07, 2026
Halozyme Therapeutics (NASDAQ:HALO) Reports Bullish Q3 CY2025
January 01, 2026
Why I Keep Buying These 10 Incredible Growth Stocks ↗
November 17, 2025
Halozyme Stock Surging On Recent Earnings Beat; Record High Ahead? ↗
November 12, 2025
Frequently Asked QuestionsIs Halozyme Therapeutics, Inc. - Common Stock publicly traded?
Yes, Halozyme Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Halozyme Therapeutics, Inc. - Common Stock trade on?
Halozyme Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Halozyme Therapeutics, Inc. - Common Stock?
The ticker symbol for Halozyme Therapeutics, Inc. - Common Stock is HALO on the Nasdaq Stock Market
What is the current price of Halozyme Therapeutics, Inc. - Common Stock?
The current price of Halozyme Therapeutics, Inc. - Common Stock is 70.40
When was Halozyme Therapeutics, Inc. - Common Stock last traded?
The last trade of Halozyme Therapeutics, Inc. - Common Stock was at 01/27/26 01:37 PM ET
What is the market capitalization of Halozyme Therapeutics, Inc. - Common Stock?
The market capitalization of Halozyme Therapeutics, Inc. - Common Stock is 10.02B
How many shares of Halozyme Therapeutics, Inc. - Common Stock are outstanding?
Halozyme Therapeutics, Inc. - Common Stock has 10B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
